Verflixt! Es sieht so aus, als wenn Sie einen veralteten Browser benutzen. Wir empfehlen Ihnen dringend Ihren Browser zu aktualisieren.
Weitere Informationen über Browser und Updates finden Sie hier

PAREXEL International

For two decades, PAREXEL International has played a key role in the pharmaceutical, biotechnology and medical device industries by partnering with clients to accelerate time-to-market, control development costs, reduce risk, and maximize return on investment. As one of the largest pharmaceutical services companies in the world, PAREXEL delivers a full range of services and solutions through its offices in 36 countries.

We have helped over 800 clients develop and launch some of the most important drugs and devices of our time. In fact, a recent study showed that we have played a role in the development of 19 of the top 20 drugs introduced in 1999 and 23 out of the top 25 drugs introduced in 2000. Our services are unmatched in the industry and include strategy development, clinical trials management, data management, biostatistical analysis, regulatory affairs, medical marketing, training, publishing and advanced technology.

Our more than 5,100 employees worldwide represent the widest possible range of therapeutic experience and knowledge. We provide centralized management and consistency for even the largest global trials and multi-site research. We apply advanced tools and Web-based technologies where they make the most sense. You get flexible one-stop shopping for the full range of drug and device development and product launch services.

Our strategic business units are:

  • Medical Communication Services (MedCom) — product launch and post-launch services
  • Clinical Research Services — clinical development services
  • PAREXEL Consulting — consulting services and products
  • Perceptive Informatics, Inc. — advanced technology


PAREXEL International

The Quays, 101-105 Oxford Road
UB8 1LZ Uxbridge
mehr als 500